drugset / Trial / NCT00018291

Specific Interventions for Agitation in Alzheimer's Disease

NCT00018291

RandomizedSingle-groupDouble-blindTreatment

Summary

This study is aimed at investigating specific pharmacological interventions in the treatment of the disruptive, agitated behavior associated with Alzheimer's patients. In addition, it is hoped that specific clinical profiles will be found to predict which treatment is most effective for these particular patients.

Timeline

Start
2001-01
Primary completion
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule
Subject Risperidone Other / unclassified

Indications